MARC record from Internet Archive

LEADER: 06802cam 2201105 a 4500
001 ocm35927529
003 OCoLC
005 20220525122459.0
008 961106s1996 nyua b 101 0 eng
010 $a 96045654
040 $aDNLM/DLC$beng$cDLC$dNLM$dCOU$dSQU$dAGL$dOCL$dOCLCQ$dBAKER$dNLGGC$dBTCTA$dLVB$dYDXCP$dCS1$dZWZ$dZAD$dBDX$dGBVCP$dOCLCO$dOCLCF$dEUX$dOCLCQ$dOCL$dOCLCQ$dGILDS$dOCLCO$dQE2$dUKMGB$dOCLCO$dOCLCA$dOCLCQ$dOCLCO
016 7 $a9617070$2DNLM
016 7 $a006374011$2Uk
020 $a1573310492$q(paper ;$qalk. paper)
020 $a9781573310499$q(paper ;$qalk. paper)
020 $a1573310484$q(cloth ;$qalk. paper)
020 $a9781573310482$q(cloth ;$qalk. paper)
035 $a(OCoLC)35927529
050 00 $aQ11$b.N5 vol. 802$aRC523
060 00 $aW1$bAN626YL v.802 1996
060 10 $aWT 155$bA6435 1996
070 0 $a500$bN484 v.802
072 0 $aX380
082 00 $a500 s$a616.8/31042$221
084 $a44.90$2bcl
084 $a44.48$2bcl
084 $a44.51$2bcl
245 00 $aApolipoprotein E genotyping in Alzheimer's disease /$cedited by Norman R. Relkin, Zaven Khachaturian, and Samuel Gandy.
260 $aNew York, NY :$bNew York Academy of Sciences,$c1996.
300 $aix, 224 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aAnnals of the New York Academy of Sciences,$x0077-8923 ;$vv. 802
500 $aBased on a conference sponsored by the National Institute on Aging and the Alzheimer's Association, held in Chicago in Oct. 1995.
504 $aIncludes bibliographical references (pages 177-224) and index.
505 0 $apt. 1. The relationship of apolipoprotein E to Alzheimer's disease -- Epidemiolgoical, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease -- Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease -- Familial and population-based studies of apolipoprotein and Alzheimer's disease -- Polygenic determinants of Alzheimer's disease: modulation of the risk of Alzheimer's disease by alpha1-antichymotrypsin -- No association between alpha1-antichymotrypsin and familial Alzheimer's disease -- Apoliopoprotein E, Abeta-amyloid, and the molecular pathology of Alzheimer's disease: therapeutic implications -- pt. 2. Diagnostic and predictive use of APOE genotyping -- Apolipoprotein E and Alzheimer's disease: a rapidly expanding field with medical and epidemiological consequences -- Predictive value of APOE genotyping in incipient Alzheimer's disease -- Early detection of Alzheimer's disease by combinging apolipoprotein E and neuroimaging -- The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease -- The effect of apolipoprotein E genotype on biochemical markers of Alzheimer's disease -- Apolipoprotein E genotype and gender influence response to tacrine therapy -- pt. 3. Ethical, medicolegal, and counseling issues raised by APOE and Alzheimer's disease -- On not jumping the gun: ethical aspects of APOE gene testing for Alzheimer's disease -- A pilot experience in genetic counseling for Alzheimer's disease: findings, relevent to the potential use of APOE genotyping in cognitively impaired individuals -- Just caring: the moral and economic costs of APOE genotyping for Alzheimer's disease -- Medicolegal, employment, and insurance issues in APOE genotyping and Alzheimer's disease -- pt. 4. Epilogue -- The National Institute on Aging/Alzheimer's Association recommendations on the application of apolioprotein E genotyping to Alzheimer's disease -- Bibliography.
530 $aAlso issued online.
508 $aBased on a conference sponsored by the National Institute on Aging and the Alzheimer's Association, held in Chicago in Oct. 1995 -t.p. verso.
540 $aCurrent copyright fee: GBP28.00$c35\0.$5Uk
650 0 $aAlzheimer's disease$xGenetic aspects$vCongresses.
650 0 $aApolipoprotein E$vCongresses.
650 12 $aAlzheimer Disease$xgenetics
650 22 $aApolipoproteins E$xdrug effects
650 22 $aApolipoproteins E$xgenetics
650 22 $aGenotype
650 6 $aMaladie d'Alzheimer$xAspect génétique$vCongrès.
650 6 $aApolipoprotéine E$vCongrès.
650 6 $aGénotypes.
650 7 $aAlzheimer's disease$xGenetic aspects.$2fast$0(OCoLC)fst00806543
650 7 $aApolipoprotein E.$2fast$0(OCoLC)fst00811437
650 7 $aAlzheimer maladie$xgénétique$xcongrès.$2fmesh
650 7 $aGénotype$xCongrès comme sujet.$2fmesh
650 7 $aApolipoprotéines E$xCongrès comme sujet.$2fmesh
650 17 $aZiekte van Alzheimer.$2gtt
650 17 $aApolipoproteïnen.$2gtt
650 17 $aGenotype.$2gtt
650 7 $aApolipoprotéines$xCongrès.$2ram
650 7 $aAlzheimer, Maladie d'$xAspect génétique$xCongrès.$2ram
650 7 $aGénotype$xCongrès.$2ram
653 0 $aAlzheimer's Disease$agenetics$acongresses
653 0 $aAlzheimer's disease$aGenetic aspects$aCongresses
653 0 $aApolipoprotein E$aCongresses
653 0 $aApolipoproteins E$adrug effects$acongresses
653 0 $aApolipoproteins E$agenetics$acongresses
653 0 $aGenotype$acongresses
655 2 $aCongress
655 4 $aCongresses.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 7 $aConference papers and proceedings.$2lcgft
655 7 $aActes de congrès.$2rvmgf
700 1 $aRelkin, Norman R.
700 1 $aKhachaturian, Zaven S.
700 1 $aGandy, Samuel.
710 2 $aNational Institute on Aging.
710 2 $aAlzheimer's Association.
776 08 $iOnline version:$tApolipoprotein E genotyping in Alzheimer's disease.$dNew York, NY : New York Academy of Sciences, 1996$w(OCoLC)988741157
830 0 $aAnnals of the New York Academy of Sciences ;$vv. 802.$x0077-8923
856 41 $uhttp://www3.interscience.wiley.com/journal/119208483/issue
856 41 $zSearch for this title in$uhttp://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1749-6632
856 4 $31850-9999$uhttp://onlinelibrary.wiley.com/$xBLDSS
938 $aBaker & Taylor$bBKTY$c80.00$d84.95$i1573310484$n0002945117$sactive
938 $aBaker & Taylor$bBKTY$c55.01$d59.96$i1573310492$n0002942362$sactive
938 $aBrodart$bBROD$n50784501$c$80.00
938 $aBaker and Taylor$bBTCP$n96045654
938 $aYBP Library Services$bYANK$n1345788
029 1 $aAU@$b000012895406
029 1 $aAU@$b000051039981
029 1 $aGBVCP$b220623708
029 1 $aNLGGC$b154282391
029 1 $aNLM$b9617070
029 1 $aNZ1$b4730178
029 1 $aUKMGB$b006374011
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 194 OTHER HOLDINGS